Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.080
0.00 (0.00%)
At close: Mar 27, 2026
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 2.52 billion as of March 27, 2026. Its market cap has decreased by -36.72% in one year.
Market Cap
2.52B
Enterprise Value
2.84B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.08
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 2.52B, a decrease of -79.20%. That is a compound annual growth rate of -32.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 2.52B | 2.00% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 3.69B |
| AIM Vaccine | 3.68B |
| Antengene Corporation | 3.28B |
| Medtide | 3.18B |
| SinoMab BioScience | 2.44B |
| Frontage Holdings | 2.31B |
| Mabpharm | 2.27B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.92B |